Journal of HIV & Retro Virus Open Access

  • ISSN: 2471-9676
  • Journal h-index: 7
  • Journal CiteScore: 0.90
  • Journal Impact Factor: 0.85
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Articles published in Journal of HIV & Retro Virus have been cited by esteemed scholars and scientists all around the world. Journal of HIV & Retro Virus has got h-index 7, which means every article in Journal of HIV & Retro Virus has got 7 average citations.

Following are the list of articles that have cited the articles published in Journal of HIV & Retro Virus.

  2021 2020 2019 2018 2017

Year wise published articles

13 64 22 18 5

Year wise citations received

36 34 18 10 32
Journal total citations count 148
Journal impact factor 0.85
Journal 5 years impact factor 0.79
Journal cite score 0.90
Journal h-index 7
Journal h-index since 2016 7
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates.
Prevalence of Tuberculosis Using Xpert MTB/RIF Assay in a Tertiary Hospital Northwest Nigeria
Correlation of Histopathological Types of Laryngeal and Nasopharyngeal Mass with PCR Detected Human Papilloma Virus -16, 18 – A Hospital Based Prospective Study
Rifampicin Resistant Tuberculosis: Prevalence and Risk Factors among Pulmonary Tuberculosis Patients in Maiduguri, Northeastern Nigeria
INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE M. TUBERCULOSIS CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA
Molecular Analysis of Rifampicin Resistance Conferring Mutations in Mycobacterium tuberculosis
Near Point-of-care and Utilisation of Decentralised GeneXpert MTB/RIF for PTB Diagnosis and PTB/HIV Co-infection Prevalence in a Resource Constrained Rural Community Hospital in Nigeria
Rapid diagnosis of multidrug-resistant tuberculosis by Xpert MTB/RIF assay
Use of Xpert MTB/RIF for the Identification of TB and Drug Resistance Among Smear-Negative and Re-Treatment Cases in Rural Areas of Ethiopia
Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
Molecular Detection of RIF Resistance in Pulmonary and Extrapulmonary Specimens in Misan Province–South of Iraq
Molecular detection of sputum Mycobacterium tuberculosis/rifampicin resistance among presumptive pulmonary tuberculosis cases in Borno state, North-Eastern Nigeria
GeneXpert MTB/RIF assay – A major milestone for diagnosing Mycobacterium tuberculosis and rifampicin-resistant cases in pulmonary and extrapulmonary specimens
Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
Multi-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria
Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high Human Immunodeficiency Virus setting in Gambella regional state, southwest Ethiopia
The Role of Brain Derived Neurotrophic Factor in HIV-Associated Neurocognitive Disorder: From the Bench-Top to the Bedside
UNPROTECTED SEX AMONG SEXUALLY ACTIVE UNMARRIED YOUNG ADULTS: A PARIAH OR PREEMPTIVE INCIDENCE
Diabetes mellitus control in a large cohort of people with HIV in care-Washington, D.C.
Sexuality and behaviour of adolescents in relationship to sexually transmitted diseases in Libreville